ACMG Highlights

Glutaric Acidemia Type I (GA I) Newborn Screening Algorithm
Glutaric Acidemia Type I (GA I) Newborn Screening Algorithm

Learn More

Glutaric Acidemia Type I (GA I) Newborn Screening ACT Sheet
Glutaric Acidemia Type I (GA I) Newborn Screening ACT Sheet

Learn More

Mucopolysaccharidosis Type II (MPS II) Newborn Screening ACT Sheet
Mucopolysaccharidosis Type II (MPS II) Newborn Screening ACT Sheet

Learn More

Upcoming Events

2022 ACMG Summer Gene Therapy Education Series OnDemand
Did you miss a webinar? Don’t worry, you can find them here:
The recorded series is free to ACMG Members and $50 for Non-members.
1. The Basics of Gene Therapy: Preclinical Development
2. Gene Therapy Targets: Inborn Errors of Metabolism
3. Gene Therapy Targets: Broadening the Scope of Therapy
4. Gene Therapy: Ethical, Social and Economic Issues


New ACCME standards are now in effect as of January 1, 2022
Learn More


Medical Necessity Webinar Series OnDemand
Learn More


Evidence Based Guidelines Webinar Series
101: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability
Available OnDemand
201: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability
Available OnDemand


ACMG Genetics101 for Healthcare Providers
Learn More


2022 ACMG Annual Clinical Genetics Meeting Digital Edition
Learn More

News and Releases

2021 ACMG Salary Survey Report Now Available: Report Provides Valuable Industry Salary Information for Medical Genetics Professionals
2021 ACMG Salary Survey Report Now Available

Learn More

ACMG-ASHG-NSGC Joint Response to Supreme Court Decision to Overrule Roe v Wade (2022)
Dobbs v. Jackson Final.ACMG-2022.pdf

Learn More

ACMG Releases Update to Secondary Findings Gene List; SF v3.1 Adds Five Genes, Including One with Variant Linked to Heart Failure in Underrepresented Populations
ACMG Releases Update to Secondary Findings Gene List; SF v3.1 Adds Five Genes-T-final.6.9

Learn More